Literature DB >> 25447494

Fetal calf sera can distort cell-based luminescent proteasome assays through heat-resistant chymotrypsin-like activity.

Susan Dettmer1, Dirk Theile1, Anja Seckinger2, Jürgen Burhenne1, Johanna Weiss3.   

Abstract

Luminescence-based proteasome activity assays use specific substrates that are supposed to be cleaved by cellular proteasome activity leading to luciferase substrates. Usually, control wells containing cell culture medium supplemented with antibiotics and fetal calf serum are used as background. Using the Proteasome-Glo chymotrypsin-like cell-based assay from Promega, we show here that fetal calf sera from different manufacturers contain heat-resistant, bortezomib-inhibitable, chymotrypsin-like activities that can interfere with proteasome activity assays. These data strongly recommend the use of pure phosphate-buffered saline (PBS) or serum-free medium during proteasome activity assays to diminish background luminescence and, thus, to obtain reliable results.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bortezomib; Carfilzomib; Fetal calf serum; Heat resistance; Proteasome activity; Proteasome-Glo chymotrypsin-like cell-based assays

Mesh:

Substances:

Year:  2014        PMID: 25447494     DOI: 10.1016/j.ab.2014.10.019

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  1 in total

1.  Proteasome inhibition correlates with intracellular bortezomib concentrations but not with antiproliferative effects after bolus treatment in myeloma cell lines.

Authors:  Susan Dettmer; Dirk Theile; Julia Schäfer; Anja Seckinger; Jürgen Burhenne; Johanna Weiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-07-15       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.